Skip to content
naulon
Not checkedNot checked for notices yet.

Treatment Effectiveness and Tolerability of Long-term Adjuvant First- and Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor at Different Doses in Patients With Stage IIA–IIIB Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Retrospective Study

Jing-Ren Ye, Pei-Hsing Chen, Jen-Hao Chuang and 4 more

Frontiers in Surgery · 2022

doi:10.3389/fsurg.2022.816018 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.